Fujifilm Corporation has announced the upcoming opening of a new "NURA" health screening centre focusing on cancer and lifestyle diseases screening in Mongolia.

The opening of the centre follows the conclusion of a technology partnership contract between the Fujifilm subsidiary Fujifilm DKH LLP, which operates three NURA centres in India, and Tavan Bogd Group, a Mongolian conglomerate. Under the partnership contract, the Tavan Bogd Group has opened a NURA health screening centre in Ulaanbaatar on September 17, 2023.

By expanding its health screening service business, Fujifilm aims to contribute toward the early detection of cancer and lifestyle diseases in emerging countries. The new NURA centre in Mongolia will be the first centre opened under a technology partnership contract.

In Mongolia, cancer and lifestyle diseases such as ischemic heart disease are leading causes of death. The number of patients dying or falling critically ill as a result of these diseases can be reduced through early disease detection followed by appropriate treatment and health guidance.  However, health screening services in Mongolia are not as widely available as in Japan, which frequently makes it difficult to detect diseases in their early stages.

Fujifilm will share its expertise it has gained from operating NURA centres in India with the Tavan Bogd Group that has worked with Fujifilm in its photo imaging business since 1995. Fujifilm and the Tavan Bogd Group will work together to create an environment that supports the delivery of high-quality screening services in Mongolia and contribute to the early detection of cancer and lifestyle diseases in Mongolia. In addition, Fujifilm and the Tavan Bogd Group will work to promote the adoption of a health screening culture in Mongolia.